Literature DB >> 11020294

Binding of a diverse set of ligands to avidin and streptavidin: an accurate quantitative prediction of their relative affinities by a combination of molecular mechanics and continuum solvent models.

B Kuhn1, P A Kollman.   

Abstract

We report calculations of free energies of binding, DeltaG(bind), between a diverse set of nine ligands and avidin as well as between a peptide and streptavidin using the recently developed MM/PBSA approach. This method makes use of a molecular dynamics simulation of the ligand-protein complex to generate a thermally averaged ensemble of conformations of the molecules that are involved in the complex formation. Based on this set of structures, a free energy of binding is calculated using molecular mechanical and continuum solvent energies as well as including estimates of the nonpolar solvation free energy and solute entropy. We compare in our simulations different classes of ligands, involving biotin derivatives, the dye 2-(4'-hydroxyazobenzene)benzoic acid (HABA), and a cyclic hexapeptide, which cover a large range of binding free energies from -5 to -20 kcal/mol. Our calculations are able to reproduce experimental DeltaG(bind) values with a very good correlation coefficient of r(2) = 0.92. This agreement is considerably better than the results obtained with an alternate approach, the linear interaction energy approximation, for this system (r(2) = 0.55).

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11020294     DOI: 10.1021/jm000241h

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  114 in total

1.  Computational study of protein specificity: the molecular basis of HIV-1 protease drug resistance.

Authors:  W Wang; P A Kollman
Journal:  Proc Natl Acad Sci U S A       Date:  2001-12-18       Impact factor: 11.205

2.  Theoretical prediction of the binding free energy for mutants of replication protein A.

Authors:  Claudio Carra; Janapriya Saha; Francis A Cucinotta
Journal:  J Mol Model       Date:  2011-12-10       Impact factor: 1.810

3.  Protein-ligand binding free energy estimation using molecular mechanics and continuum electrostatics. Application to HIV-1 protease inhibitors.

Authors:  V Zoete; O Michielin; M Karplus
Journal:  J Comput Aided Mol Des       Date:  2003-12       Impact factor: 3.686

4.  Binding affinities in the SAMPL3 trypsin and host-guest blind tests estimated with the MM/PBSA and LIE methods.

Authors:  Paulius Mikulskis; Samuel Genheden; Patrik Rydberg; Lars Sandberg; Lars Olsen; Ulf Ryde
Journal:  J Comput Aided Mol Des       Date:  2011-12-25       Impact factor: 3.686

5.  A fragment-based approach to the SAMPL3 Challenge.

Authors:  John L Kulp; Seth N Blumenthal; Qiang Wang; Richard L Bryan; Frank Guarnieri
Journal:  J Comput Aided Mol Des       Date:  2012-05       Impact factor: 3.686

6.  Absolute free energy of binding of avidin/biotin, revisited.

Authors:  Ignacio J General; Ralitsa Dragomirova; Hagai Meirovitch
Journal:  J Phys Chem B       Date:  2012-02-27       Impact factor: 2.991

7.  Calculation of absolute protein-ligand binding affinity using path and endpoint approaches.

Authors:  Michael S Lee; Mark A Olson
Journal:  Biophys J       Date:  2005-11-11       Impact factor: 4.033

8.  Processing multimode binding situations in simulation-based prediction of ligand-macromolecule affinities.

Authors:  Akash Khandelwal; Viera Lukacova; Daniel M Kroll; Soumyendu Raha; Dogan Comez; Stefan Balaz
Journal:  J Phys Chem A       Date:  2005-07-28       Impact factor: 2.781

9.  Thermodynamic basis for promiscuity and selectivity in protein-protein interactions: PDZ domains, a case study.

Authors:  Nathalie Basdevant; Harel Weinstein; Marco Ceruso
Journal:  J Am Chem Soc       Date:  2006-10-04       Impact factor: 15.419

10.  Comparison between Generalized-Born and Poisson-Boltzmann methods in physics-based scoring functions for protein structure prediction.

Authors:  Matthew C Lee; Rong Yang; Yong Duan
Journal:  J Mol Model       Date:  2005-08-12       Impact factor: 1.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.